The short answer
A BPC-157 certificate of analysis should come from an independent ISO/IEC 17025 laboratory, state HPLC purity against a specification, confirm identity by mass spectrometry, and be tied to the exact lot number on the vial. Treat any certificate you cannot verify with the issuing lab as no certificate at all.
What BPC-157 is, in research terms
BPC-157 is a synthetic pentadecapeptide — a 15-amino-acid sequence derived from a protein found in gastric juice, which is why literature often refers to it as "Body Protection Compound". In published work it appears almost entirely in preclinical models: cell culture and animal studies investigating tissue-repair and inflammatory pathways.
Two things are worth stating plainly, because reputable sources state them. Human clinical evidence is extremely limited — the peer-reviewed literature is dominated by rodent models — and BPC-157 is not an approved medicine in the United States or elsewhere. It is supplied, and should only be used, as a laboratory reference material for in-vitro and preclinical research.
For a research setting, the practical consequence is that what matters most about a vial is not a claim about what the peptide does. It is whether the material in the vial is the peptide, at the purity stated, free of contaminants that would confound an assay.
What a real certificate of analysis has to show
A certificate of analysis is only evidence if it is independent, specific and verifiable. Independent means the testing laboratory has no financial relationship with the seller — a supplier certifying its own material is a conflict of interest, not a control. Accreditation to ISO/IEC 17025 is the meaningful standard, because it audits the laboratory's methods and competence, not just its results.
Specific means the certificate is bound to a single lot. A purity figure with no lot number attached tells you nothing about the vial in your hand: a supplier can publish a genuine certificate for one batch and ship another. The lot printed on the vial should appear on the certificate.
Verifiable is the part most suppliers fail. A PDF hosted on a vendor's own website can be edited in a minute. The stronger form is a certificate you can confirm on the issuing laboratory's own portal, using a code printed on the document — so the result you are reading comes from the lab's records, not the seller's web server.
Reading the panel: what each test rules out
Purity by HPLC (RP-HPLC, typically at 214 nm) reports the target peptide as a percentage of all peptide-related peaks. Research-grade material is generally specified at ≥95%, with serious suppliers reporting ≥98–99%. Note the wording carefully: area-normalisation percentages describe peptide-related content, not everything in the vial.
Identity confirmation — by mass spectrometry or retention-time comparison against a reference standard — answers a different question from purity: is this the right molecule at all? A high purity figure for the wrong peptide is worthless, which is why identity and purity should both appear.
The remaining panel rules out what would otherwise confound results: elemental impurities (heavy metals) by ICP-MS per USP ⟨233⟩, bacterial endotoxin per USP ⟨85⟩, and sterility. Endotoxin in particular can distort inflammatory-pathway assays — precisely the pathways BPC-157 is studied in — so a purity-only certificate leaves a meaningful gap.
Questions researchers ask
How can I tell if BPC-157 is real or fake?
Identity is a laboratory question, not a visual one — powder appearance tells you nothing. Confirmation comes from mass spectrometry matching the expected molecular mass, reported on a lot-specific certificate from an independent laboratory. Material sold without batch-specific third-party analysis, or with a certificate you cannot verify at the issuing lab, should be treated as unverified.
What does 99% purity actually mean on a peptide COA?
It is an HPLC area-normalisation figure: the target peptide as a percentage of all peptide-related peaks detected, typically at 214 nm. It describes peptide-related content only — it is not a statement that 99% of the vial's mass is peptide, and it says nothing about endotoxin, heavy metals or sterility.
Why is net peptide content lower than the labelled weight?
Synthetic peptides are usually isolated as salts, so a portion of the powder's mass is counterion (commonly TFA) plus residual water rather than peptide. Net peptide content quantifies the actual peptide mass, which is why it can read below the labelled figure. A certificate that reports it is being more transparent, not less accurate.
How current does a certificate of analysis need to be?
It must correspond to the lot you received, not merely to the product. Every synthesis run is analysed separately, so a certificate for an earlier batch says nothing about the current one. Check that the lot number on the certificate matches the lot printed on the vial before treating the results as applicable.
Does purity change after a peptide is reconstituted?
Certificates describe the lyophilised powder as analysed. Once reconstituted, a peptide in solution can degrade over time depending on storage, temperature and handling, so a later re-test of the same material may not match the original figure. Handle and store reconstituted material according to your own protocol.
What tests should a full quality panel include?
Purity by RP-HPLC and identity by mass spectrometry establish what the material is. Beyond that, elemental impurities by ICP-MS (USP ⟨233⟩), bacterial endotoxin (USP ⟨85⟩) and sterility rule out contaminants that would confound results. A purity-only certificate leaves those questions unanswered.
At a glance
- Class
- Synthetic pentadecapeptide (15 amino acids)
- Also searched as
- Body Protection Compound 157, PL 14736
- Typical research specification
- ≥ 95% by RP-HPLC (area normalisation, 214 nm)
- Form
- Lyophilised powder
- Status
- Research use only — not an approved medicine; no human or veterinary use
How our BPC-157 lots test
Applying the same standard described above to our own material. Each certificate below opens on the issuing laboratory's portal— not a PDF hosted here — so you are reading the lab's record, not ours.
Sources
Written from primary literature and published standards — never from other suppliers' marketing copy.
- Multifunctionality and Possible Medical Application of the BPC 157 Peptide — literature and patent review (PMC) ↗
- Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing (PMC) ↗
- BPC-157 — compound record, PubChem (NIH) ↗
- USP General Chapter ⟨85⟩ Bacterial Endotoxins Test ↗
- USP General Chapter ⟨233⟩ Elemental Impurities — Procedures ↗
- ISO/IEC 17025 — testing and calibration laboratory competence ↗
Written by Ivory Science. Scientific review: pending appointment of a named reviewer. Until then this page cites its sources directly so every claim can be checked at origin.
Related notes
For research use only. Not for human or veterinary use, ingestion or administration. Nothing here is medical advice, and no statement on this page has been evaluated by the FDA. BPC-157 is not an approved medicine.